| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $134.5M | -3.9% |
| Cost of Revenue | $31.5M | -23.2% |
| Gross Profit | $103.0M | +4.1% |
| R&D Expense | $38.5M | +12.2% |
| SG&A Expense | $112.7M | +11.1% |
| Operating Income | -$48.2M | -30.7% |
| Interest Expense | $19K | -9.5% |
| Pre-tax Income | -$38.9M | -41.9% |
| Income Tax | $66K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.9M | +19.4% |
| Short-term Investments | $208.2M | -5.6% |
| Accounts Receivable | $23.4M | -22.2% |
| Inventory | $31.6M | +43.4% |
| Current Assets | $287.5M | -2.2% |
| Total Assets | $311.8M | -2.1% |
| Current Liabilities | $26.3M | +1.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.5M | +8.5% |
| Capital Expenditures | $3.8M | -29.6% |
| Investing Cash Flow | $16.9M | +117.0% |
| Financing Cash Flow | $1.9M | -98.5% |
| Free Cash Flow | -$19.3M | +13.6% |
| +32.0% |
| Net Income | -$38.9M | -41.8% |
| EPS (Basic) | -$0.95 | -33.8% |
| EPS (Diluted) | -$0.95 | -33.8% |
| Total Liabilities |
| $36.1M |
| -3.2% |
| Stockholders' Equity | $275.7M | -2.0% |